Zhiming Shan

机构：Zhengzhou Children's Hospital, Zhejiang Provincial People's Hospital, University of Hong Kong - Shenzhen Hospital, Hangzhou Medical College, University of Hong Kong · ORCID：0000-0002-4575-3933

发表论文 51 篇 · 总被引 661 次 · h-index 15

代表论文

• Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents (2021 · Science Translational Medicine · 被引 61)
• Studies on CRMP2 SUMOylation–deficient transgenic mice identify sex-specific Nav1.7 regulation in the pathogenesis of chronic neuropathic pain (2020 · Pain · 被引 38)
• LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis (2021 · Frontiers in Medicine · 被引 32)
• Three years’ experience of quality monitoring program on pre‐analytical errors in china (2021 · Journal of Clinical Laboratory Analysis · 被引 22)
• Comparative Efficacy of Fentanyl and Morphine in Patients with or At Risk for Acute Respiratory Distress Syndrome: A Propensity Score-Matched Cohort Study (2021 · Drugs in R&D · 被引 20)
• The natural product argentatin C attenuates postoperative pain via inhibition of voltage‐gated sodium and T‐type voltage‐gated calcium channels (2022 · British Journal of Pharmacology · 被引 18)